[{"Assets_0_FY_USD":270060000.0,"EarningsPerShareBasic_1_FY_USD":0.61,"EarningsPerShareBasic_4_FY_USD":3.44,"EarningsPerShareDiluted_1_FY_USD":0.58,"EarningsPerShareDiluted_4_FY_USD":3.27,"NetCashProvidedByUsedInOperatingActivities_4_FY_USD":58919000.0,"NetIncomeLoss_4_FY_USD":51943000.0,"StockholdersEquity_0_FY_USD":179144000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":15908211.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":15102890.0,"Ticker":"EGRX","CIK":"827871","name":"EAGLE PHARMACEUTICALS, INC.","OfficialName":"Eagle Pharmaceuticals Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"635235963.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180226"}]